MEXICO CITY (Reuters) — Mexican authorities said they are studying the case of a 32-year-old female doctor who was hospitalized after receiving the Pfizer-BioNTech COVID-19 vaccine.
The doctor, whose name has not been released, was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing and a skin rash.
“The initial diagnosis is encephalomyelitis,” the Health Ministry said in a statement released on Friday night. Encephalomyelitis is an inflammation of the brain and spinal cord.
Shared last year, but with the talk of future regenerative medicine I think it is important: Regenerative medicine aims to engineer tissue constructs that can recapitulate the functional and structural properties of native organs. Most novel regenerative therapies are based on the recreation of a three-dimensional environment that can provide essential guidance for cell organization, survival, and function, which leads to adequate tissue growth. The primary motivation in the use of conductive nanomaterials in tissue engineering has been to develop biomimetic scaffolds to recapitulate the electrical properties of the natural extracellular matrix, something often overlooked in numerous tissue engineering materials to date. In this review article, we focus on the use of electroconductive nanobiomaterials for different biomedical applications, particularly, very recent advancements for cardiovascular, neural, bone, and muscle tissue regeneration. Moreover, this review highlights how electroconductive nanobiomaterials can facilitate cell to cell crosstalk (i.e., for cell growth, migration, proliferation, and differentiation) in different tissues. Thoughts on what the field needs for future growth are also provided.
Get early access to our latest psychology lectures: http://bit.ly/new-talks.
In this talk, Anil looks into the mechanisms at play when experiencing both inner and outer phenomena, the central components of which are prediction and perception.
Anil Seth is Professor of Cognitive and Computational Neuroscience at the University of Sussex, and the Co-Director of the Sackler Centre for Consciousness Science. He is a Wellcome Trust Engagement Fellow, and a Senior Fellow of the Canadian Institute for Advanced Research. Professor Seth is Editor-in-Chief of Neuroscience of Consciousness, sits on the steering group and advisory board of the Human Mind Project, and was President of the British Science Association Psychology Section in 2017.
He is the co-author of the ‘30 Second Brain’, and contributes regularly to a variety of media including New Scientist, The Guardian, and the BBC. His 2017 TED talk has been viewed more than 9 million times. Professor Seth’s research bridges neuroscience, mathematics, artificial intelligence, computer science, psychology, philosophy and psychiatry. He has also worked extensively with playwrights, dancers and other artists to shape a truly humanistic view of consciousness and self. You can keep up to date with his work at www.anilseth.com.
—
The Weekend University’s mission is to make the best ideas in psychology more accessible to the general public.
Summary: Treatment with LAU-0901, a synthetic molecule that blocks pro-inflammatory platelet-activating factor, in addition to aspirin-triggered NPD1, reduced the size of damage areas in the brain, initiated repair mechanisms, and improved behavioral recovery following ischemic stroke.
Source: LSU
Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that a combination of an LSU Health-patented drug and selected DHA derivatives is more effective in protecting brain cells and increasing recovery after stroke than a single drug.
A pair of monkeys were able to “see” and recognize individual letter shapes generated by arrays of electrodes implanted in their brains – without using their eyes. Previously, sight-restoring implants were placed in the retina, but these new implants were placed in the visual cortex. They achieved the highest resolution yet for such technology.
The visual cortex is like a cinema screen in our skull, with each area on its surface mapping to the visual field. Placing a patch of electrodes on the surface that activate like pixels will make a person “see” whatever points get activated. For example, if an L-shaped pattern of electrodes in contact with the visual cortex is activated, they will see a pixelated L.
Dr. Nicole Prause, PhD is an American neuroscientist researching human sexual behavior, addiction, and the physiology of sexual response. She is also the founder of Liberos LLC, an independent research institute and biotechnology company.
Dr. Prause obtained her doctorate in 2007 at Indiana University Bloomington, with joint supervision by the Kinsey Institute for Research in Sex, Gender, and Reproduction, with her areas of concentration being neuroscience and statistics. Her clinical internship, in neuro-psychological assessment and behavioral medicine, was with the VA Boston Healthcare System’s Psychology Internship Training Program. Her research fellowship was in couples’ treatment of alcoholism was at Harvard University.
Dr. Prause became a tenure track faculty member at Idaho State University at the age of 29. After three years there, she accepted a position as a Research Scientist at the Mind Research Network, a neuro-imaging facility in Albuquerque, New Mexico.
In 2012, Dr. Prause was elected a full member of the International Academy of Sex Research and accepted a position as a Research Scientist on faculty at the University of California, Los Angeles in the David Geffen School of Medicine. While there, she was promoted to Associate Research Scientist in 2014.
Dr. Prause founded Liberos LLC in 2015 and she continues to practice as licensed psychologist in California.
This is another example of how autism is now being used as an advantage in business. What people previously saw as a weakness turned out to be a strength. 😃
Gordon Douglas struggled to find work because of his “differences”. Now his neurodiversity is making him a sought-after employee.
An experimental drug reversed age-related declines in memory and mental flexibility in old mice after just a few doses, according to a study by researchers from the University of California, San Francisco (UCSF).
The drug, ISRIB, has previously been shown in other studies to restore normal cognitive function in mice after traumatic brain injury, enhance memory in healthy mice and mice with Down syndrome, as well as prevent noise-related hearing loss.
